Evidence map›Paper›PMID 22927440›Full record

ArticleThe Journal of biological chemistry2012

Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.

Rym Benabid, Julien Wartelle, Laurette Malleret, Nicolas Guyot, Sophie Gangloff, François Lebargy, Azzaq Belaaouaj

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Serine protease inhibitor derived fromFrontiers in cellular and infection microbiology · 2022
    Article
  11. Article
  12. Article
  13. Protease-Antiprotease Imbalance in Bronchiectasis.International journal of molecular sciences · 2021
    Review
  14. Pathogenesis and Management of COVID-19.Journal of xenobiotics · 2021
    Review
  15. Article
  16. Article
  17. Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2020
    Review
  18. Article
  19. Review
  20. Proteases in Pemphigoid Diseases.Frontiers in immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Rym BenabidInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
Julien WartelleInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
Laurette MalleretInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
Nicolas GuyotInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
Sophie GangloffEA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
François LebargyInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France.
Azzaq BelaaouajInserm Avenir Program, CHU de Reims, Maison Blanche, Reims 51092, France; EA 4303, Inflammation and Immunity of the Respiratory Epithelium, CHU de Reims, Maison Blanche, Reims 51092, France. Electronic address: azzaq.belaaouaj@univ-reims.fr.
Centre Hospitalier Universitaire de Reims · FRInserm · FRFondation de l'Avenir · FRHôpital Maison Blanche · FRUniversité de Reims Champagne-Ardenne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is accumulating evidence that following bacterial infection, the massive recruitment and activation of the phagocytes, neutrophils, is accompanied with the extracellular release of active neutrophil elastase (NE), a potent serine protease. Using NE-deficient mice in a clinically relevant model of Pseudomonas aeruginosa-induced pneumonia, we provide compelling in vivo evidence that the absence of NE was associated with decreased protein and transcript levels of the proinflammatory cytokines TNF-α, MIP-2, and IL-6 in the lungs, coinciding with increased mortality of mutant mice to infection. The implication of NE in the induction of cytokine expression involved at least in part Toll-like receptor 4 (TLR-4). These findings were further confirmed following exposure of cultured macrophages to purified NE. Together, our data suggest strongly for the first time that NE not only plays a direct antibacterial role as it has been previously reported, but released active enzyme can also modulate cytokine expression, which contributes to host protection against P. aeruginosa. In light of our findings, the long held view that considers NE as a prime suspect in P. aeruginosa-associated diseases will need to be carefully reassessed. Also, therapeutic strategies aiming at NE inhibition should take into account the physiologic roles of the enzyme.

Indexed as

Immunity, InnateAnimalsCytokinesGene Expression RegulationLeukocyte ElastaseLungMiceMice, KnockoutPneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsToll-Like Receptor 4CytokinesLeukocyte ElastaseTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID22927440
PMCPMC3471768
OpenAlexW1981678052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.